FDA clears Devon Medical Products’ extriCARE 2400 NPWT system

NewsGuard 100/100 Score

Devon Medical Products, a global medical device designer, manufacturer, and distributor, today announced it has received Food & Drug Administration (FDA) 510(k) clearance to market its extriCARE™ 2400 Negative Pressure Wound Therapy (NPWT) system.

The extriCARE™ 2400 pump weighs only 8.6 ounces and offers patients with specific wounds the ability to live a more active wound-healing lifestyle. The pump pairs with Devon Medical Products' easy-to-apply, anatomically fitted bandages that create tight seals around wounds on various areas of the body. Together these technologies promote blood flow and remove exudates into a disposable canister located on the extriCARE™ 2400 pump.

"We designed and built the extriCARE™ NPWT system with patients and caregivers in mind after discussions with expert wound care nurses, physicians, and wound management thought leaders," says Dr. John A. Bennett, president of Devon Medical Products. "Ease of application, portability, and bandages creating airtight seals were deemed the most vital features necessary for safe and effective wound closure. The extriCARE™ encompasses these traits, and we're excited to offer this innovation in negative pressure wound therapy to healthcare professionals and patients."

The U.S. patent pending extriCARE™ 2400 pump is intended for the management of chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, diabetic and pressure ulcers, flaps, and grafts. Using the extriCARE™ significantly reduces wound preparation time. The extriCARE™ can be utilized in acute hospital settings, wound clinics, nursing homes, and inside the home under supervision of a trained healthcare professional.

Devon Medical Products will showcase the extriCARE™ 2400 pump at the Medtrade Spring Conference (booth #848) in Las Vegas from April 11-12 and at the Symposium on Advanced Wound Care and Wound Healing Society meeting (booth #344) in Atlanta from April 19-21. The company will also display its CircuFlow™ compression therapy pumps for the treatment of venous insufficiency and swelling related to Lymphedema, as well as its ArterioFlow™ 7500 arterial compression pump used to increase blood circulation and prevent diabetic ulcers.

Source:

Devon Medical Products    

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ovum AI launches Australia’s first longitudinal dataset to revolutionize women’s healthcare